Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities
- 3 November 2021
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 5 (5) , 1709-1718
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Gynecologic cancer screening and communication with health care providers in women with Lynch syndromeClinical Genetics, 2013
- Specialists’ Perceptions of Hereditary Colorectal Cancer Screening in Newfoundland and LabradorCurrent Oncology, 2012
- Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillanceCancer, 2011
- Significant differences among physician specialties in management recommendations of BRCA1 mutation carriersBreast Cancer Research and Treatment, 2011
- Prospective Study of Combined Colon and Endometrial Cancer Screening in Women With Lynch Syndrome: A Patient-Centered ApproachJournal of Oncology Practice, 2011
- Long‐term compliance with endoscopic surveillance for familial adenomatous polyposisColorectal Disease, 2010
- Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch SyndromeAmerican Journal of Gastroenterology, 2010
- Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriersFamilial Cancer, 2010
- Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic CounselorsJournal of Genetic Counseling, 2007